CureMeAbroad
Constantinos Zamboglou

Constantinos Zamboglou

Cancer Treatment

13+

Years of Experience

About Constantinos Zamboglou

<p style="text-align:justify;"><span style="background-color:transparent;color:#000000;"><u>Education</u></span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">09 / 2004 – 07 / 2006<i>                </i>Movie Director School<i>, ANT1 Movie School Athens,</i> Greece, Degree “Television Director”, grade point average: B</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">09 / 2006 – 08 / 2008<i>                </i>Medical School<i>, Semmelweis University Budapest,</i> Hungary, Medical preliminary examination (Physikum), grade point average: A</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">10 / 2008 – 05 / 2013<i>                </i>Medical School<i>, Albert-Ludwigs-Universität Freiburg,</i> Germany, State examination in medicine, grade point average: A</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I,<i> Albert-Ludwigs-Universität Freiburg, </i>Germany<i>, </i>Doctoral thesis, grade: <i>summa cum</i> <i>laude</i></span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">03 / 2020                                      <i>Medical Center University of Freiburg,</i> Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">09 / 21 – 08 / 23                         <i>MHBA, Friedrich Alexander University, </i>Nuernberg, Germany</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;"><u>Professional Career</u></span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                </span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;"><u>Professional Memberships and Distinctions</u></span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      </span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2021           Best Abstract, EMUC congress 2021, Athens, Greece</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation</span></p><p style="text-align:justify;"><span style="background-color:transparent;color:#000000;">2023           Invited member of the ESTRO focus group “Urology”</span></p>

Good to know

Speciality

• Cancer Treatment

Language Spoken

• English

Awards

  • • 2023 – Annual ARO study prize from the German Cancer Foundation for the HypoFocal-SBRT study.
  • • 2021 – Best Abstract award at the EMUC congress in Athens, Greece.
  • • 2020 – Herman-Holthusen Award from the German Society of Radiation Oncology (DEGRO).
  • • 2019 – Poster prize at the Uro-Oncological Symposium in Magdeburg.
  • • 2017 – Poster prize at the DEGRO annual meeting in Berlin.
  • • 2010 – Sanofi-Aventis poster prize at the German Society of Pharmacology annual meeting in Mainz.
  • • Invited member of the ESTRO-ACROP guideline committee for prostate cancer.
  • • Member of the German expert panel for prostate cancer of DEGRO.
  • • Invited member of the ESTRO focus group “Urology”.
  • • Degree in Television Direction from ANT1 Movie School Athens (2006).

Clinical oncologist

Since 2022 – Vice Medical Director at the German Medical Institute (GMI) in Limassol, Cyprus.

Since 2022 – Prostate cancer research group leader at the Medical Center University of Freiburg.

2021–2022 – Advanced Clinician Scientist in the Bertha-Ottenstein program at Freiburg.

2021 – Head of the Section of Interventional Radiation Oncology at University of Freiburg.

Since 2019 – Consultant at the Department of Radiation Oncology, University of Freiburg.

2017–2020 – Clinician Scientist at the Bertha-Ottenstein program, University of Freiburg, Germany.

2013–2019 – Resident at the Medical Center University of Freiburg.

All Procedures

Performed by Constantinos Zamboglou

Cancer Treatment

Cancer Treatment

Cancer treatment abroad gives patients an access to world-class oncology centers offering chemotherapy, immunotherapy, targeted therapy, radiation, and surgical oncology. Multidisciplinary tumor boards of oncologists, surgeons, and radiologists collaborate to design personalized treatment plans. Oncology care costs can be financially devastating in many countries. Advanced cancer treatments that cost $80,000 to $200,000 at home may be available for $15,000 to $50,000 abroad at JCI-accredited hospitals with equally qualified oncologists and the latest treatment technologies. International cancer centers provide comprehensive care including PET-CT imaging, genomic tumor profiling, and access to clinical trials not available locally. Dedicated oncology case managers guide patients through every step of their treatment journey. The oncologist's experience and the hospital's technology are the most important factors to consider to ensure authenticity. Always confirm your treating team includes board-certified oncologists and that the facility is accredited by a recognized international body. Adherence to your full treatment protocol, nutritional support, and psychological well-being during treatment all significantly influence outcomes.

CureMeAbroadIs Absolutely Free

Just discovery so you can choose what's right for you!

Get a free consultation with CureMeAbroad

World's No. 1 Medical Discovery Platform

Help Me Plan
My Treatment Abroad

End-to-End Treatment Planning, specifically curated to your needs. Just a call away

Plan your treatment abroad with CureMeAbroad